📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Matrx Pharmaceuticals

1.1 - Company Overview

Matrx Pharmaceuticals Logo

Matrx Pharmaceuticals

Headquarter: Poland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of pharmaceuticals.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Matrx Pharmaceuticals

Exzell Pharma Logo

Exzell Pharma

HQ: Canada Website
  • Description: Provider of medicines, healthcare and biopharma-based products, including EsopH OTC therapy for GERD that relieves heartburn and can be used with PPI prescriptions; Swiss Natural vitamins, supplements and minerals from natural sources; Salinex nasal spray to hydrate and cleanse; PediaVit vitamins and iron for infants and children; Koena multi-strain probiotics; and Ozonol ointment for scrapes, minor burns, and skin irritations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Exzell Pharma company profile →
Apotheca Biosciences Logo

Apotheca Biosciences

HQ: United States Website
  • Description: Provider of cutting-edge medical products, nutraceuticals, and formulation and delivery technologies for the healthcare and consumer care industry, including transdermal, sublingual, and nasal delivery technologies for precise, controlled dosing of cannabinoids.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Apotheca Biosciences company profile →
KalVista Pharmaceuticals Logo

KalVista Pharmaceuticals

HQ: United States Website
  • Description: Provider of oral plasma kallikrein inhibitors for on-demand treatment of hereditary angioedema (HAE), including Sebetralstat being evaluated in the KONFIDENT Phase 3 Trial; developer of oral Factor XIIa inhibitors to prevent thrombosis with reduced bleeding risk; and other oral therapies targeting the kallikrein-kinin system, including HAE. An ophthalmology company with a focus on diabetic macular edema (DME).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full KalVista Pharmaceuticals company profile →
Imbria Logo

Imbria

HQ: United States Website
  • Description: Provider of clinical-stage cardiometabolic therapies centered on ninerafaxstat, an investigational cardiac mitotrope designed to enhance cellular energy metabolism by increasing energy per molecule of oxygen consumed. Conducts Phase 2 trials: IMPROVE-HCM (non-obstructive HCM), IMPROVE-ISCHEMIA (stable angina/chronic coronary syndrome), and IMPROVE-DiCE (type 2 diabetes with HFpEF).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Imbria company profile →
Axys Pharmaceuticals Logo

Axys Pharmaceuticals

HQ: United States Website
  • Description: Provider of discovery, design, and development services for therapeutic small molecules addressing significant markets with major unmet medical needs; collaborates with large pharmaceutical companies to discover therapeutics for chronic diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Axys Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Matrx Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Matrx Pharmaceuticals

2.2 - Growth funds investing in similar companies to Matrx Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Matrx Pharmaceuticals

4.2 - Public trading comparable groups for Matrx Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Matrx Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Matrx Pharmaceuticals

What does Matrx Pharmaceuticals do?

Matrx Pharmaceuticals is a provider of pharmaceuticals.

Who are Matrx Pharmaceuticals's competitors?

Matrx Pharmaceuticals's competitors and similar companies include Exzell Pharma, Apotheca Biosciences, KalVista Pharmaceuticals, Imbria, and Axys Pharmaceuticals.

Where is Matrx Pharmaceuticals headquartered?

Matrx Pharmaceuticals is headquartered in Poland.

How many employees does Matrx Pharmaceuticals have?

Matrx Pharmaceuticals has 1,000 employees 🔒.

When was Matrx Pharmaceuticals founded?

Matrx Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Matrx Pharmaceuticals in?

Matrx Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Matrx Pharmaceuticals

Who are the top strategic acquirers in Matrx Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Matrx Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Matrx Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Matrx Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Matrx Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Matrx Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Matrx Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Matrx Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Matrx Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Matrx Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Matrx Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Matrx Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Matrx Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Matrx Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Matrx Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Matrx Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Matrx Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Matrx Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Matrx Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Matrx Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Matrx Pharmaceuticals